107 related articles for article (PubMed ID: 14718629)
41. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
Cotter MA; Robertson ES
Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
[TBL] [Abstract][Full Text] [Related]
42. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
Sun Z; Jha HC; Robertson ES
J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
[TBL] [Abstract][Full Text] [Related]
43. Bovine herpesvirus 4 ORF73 is dispensable for virus growth in vitro, but is essential for virus persistence in vivo.
Thirion M; Machiels B; Farnir F; Donofrio G; Gillet L; Dewals B; Vanderplasschen A
J Gen Virol; 2010 Oct; 91(Pt 10):2574-84. PubMed ID: 20592111
[TBL] [Abstract][Full Text] [Related]
44. KSHV Genome Replication and Maintenance in Latency.
Ueda K
Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
[TBL] [Abstract][Full Text] [Related]
45. A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin.
Viejo-Borbolla A; Kati E; Sheldon JA; Nathan K; Mattsson K; Szekely L; Schulz TF
J Virol; 2003 Jun; 77(12):7093-100. PubMed ID: 12768028
[TBL] [Abstract][Full Text] [Related]
46. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids.
Grundhoff A; Ganem D
J Virol; 2003 Feb; 77(4):2779-83. PubMed ID: 12552022
[TBL] [Abstract][Full Text] [Related]
47. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
48. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.
Fejér G; Medveczky MM; Horvath E; Lane B; Chang Y; Medveczky PG
J Gen Virol; 2003 Jun; 84(Pt 6):1451-1462. PubMed ID: 12771414
[TBL] [Abstract][Full Text] [Related]
49. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome.
Lim C; Sohn H; Lee D; Gwack Y; Choe J
J Virol; 2002 Oct; 76(20):10320-31. PubMed ID: 12239308
[TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
[TBL] [Abstract][Full Text] [Related]
51. Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri.
Hall KT; Giles MS; Goodwin DJ; Calderwood MA; Carr IM; Stevenson AJ; Markham AF; Whitehouse A
J Virol; 2000 Aug; 74(16):7331-7. PubMed ID: 10906186
[TBL] [Abstract][Full Text] [Related]
52. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
53. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Garber AC; Shu MA; Hu J; Renne R
J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
[TBL] [Abstract][Full Text] [Related]
54. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.
Hellert J; Weidner-Glunde M; Krausze J; Lünsdorf H; Ritter C; Schulz TF; Lührs T
Proc Natl Acad Sci U S A; 2015 May; 112(21):6694-9. PubMed ID: 25947153
[TBL] [Abstract][Full Text] [Related]
55. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
56. The gene product encoded by ORF 57 of herpesvirus saimiri regulates the redistribution of the splicing factor SC-35.
Cooper M; Goodwin DJ; Hall KT; Stevenson AJ; Meredith DM; Markham AF; Whitehouse A
J Gen Virol; 1999 May; 80 ( Pt 5)():1311-1316. PubMed ID: 10355778
[TBL] [Abstract][Full Text] [Related]
57. Structure and function of latency-associated nuclear antigen.
Verma SC; Lan K; Robertson E
Curr Top Microbiol Immunol; 2007; 312():101-36. PubMed ID: 17089795
[TBL] [Abstract][Full Text] [Related]
58. KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence.
Komatsu T; Ballestas ME; Barbera AJ; Kelley-Clarke B; Kaye KM
Virology; 2004 Feb; 319(2):225-36. PubMed ID: 14980483
[TBL] [Abstract][Full Text] [Related]
59. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
60. Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence.
Ye FC; Zhou FC; Yoo SM; Xie JP; Browning PJ; Gao SJ
J Virol; 2004 Oct; 78(20):11121-9. PubMed ID: 15452232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
